Insider Trading & Ownership - New Enterprise Associates 16, L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for New Enterprise Associates 16, L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-12-23
Purchase
2024-12-23
4:40 pm
Marker Therapeutics Inc. MRKR New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
BASKETT FOREST
Chang Carmen
Behbahani Ali
Florence Anthony A. Jr.
Makhzoumi Mohamad
SANDELL SCOTT D
Walker Paul Edward
10% Owner
554,250 $3.2 $1,773,600 1,625,678
(Direct)
View
2022-05-24
Sale
2022-05-26
6:26 pm
GENOCEA BIOSCIENCES INC. GNCA New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
10,376,936 $0.07234 $750,662 0
(Direct)
View
2022-04-11
Purchase
2022-04-13
5:00 pm
Trevi Therapeutics Inc. TRVI New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
2,631,578 $1.9 $4,999,998 10,421,428
(Direct)
View
2021-12-10
Sale
2021-12-27
4:40 pm
Metacrine Inc. MTCR New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
497,270 $0.9944 $494,483 2,563,257
(Direct)
View
2021-10-18
Purchase
2021-10-19
9:09 pm
Trevi Therapeutics Inc. TRVI New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
1,851,852 $0 $0 11,493,554
(Direct)
View
2021-03-16
Purchase
2021-03-18
5:08 pm
Marker Therapeutics Inc. MRKR New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
5,714,285 $1.75 $9,999,999 10,714,285
(Direct)
View
2020-12-04
Purchase
2020-12-07
5:06 pm
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
4,398,602 $0.622 $2,735,930 11,949,017
(Direct)
View
2020-09-18
Purchase
2020-09-22
5:40 pm
Metacrine Inc. MTCR New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
769,230 $13 $9,999,990 3,060,527
(Direct)
View
2020-07-24
Purchase
2020-07-28
5:19 pm
GENOCEA BIOSCIENCES INC. GNCA New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
3,151,260 $2.25 $7,090,335 13,528,196
(Direct)
View
2020-06-30
Purchase
2020-07-01
5:45 pm
Akouos Inc. AKUS New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
588,235 $17 $9,999,995 4,294,207
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-13
Other
2023-06-15
4:22 pm
N/A
N/A
Mirum Pharmaceuticals Inc. MIRM New Enterprise Associates 16 L.P.
10% Owner
2,000,000 $0 4,186,243
(Direct)
View
2022-11-30
Equity Swap
2022-12-02
5:01 pm
N/A
N/A
Akouos Inc. AKUS New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
4,294,207 $0 0
(Direct)
View
2020-09-18
Conversion
2020-09-22
5:40 pm
N/A
N/A
Metacrine Inc. MTCR New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
2,291,297 $0 3,060,527
(Direct)
View

Ownership
2020-09-15
5:21 pm
N/A
N/A
Metacrine Inc. MTCR New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
0 $0 2,291,297
(Direct)
View
2020-06-30
Conversion
2020-07-01
5:45 pm
N/A
N/A
Akouos Inc. AKUS New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
3,705,972 $0 4,294,207
(Direct)
View

Ownership
2020-06-25
7:14 pm
N/A
N/A
Akouos Inc. AKUS New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
0 $0 3,705,972
(Direct)
View